Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Glauser, A.
Right arrow Articles by Hess, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glauser, A.
Right arrow Articles by Hess, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1580-1587
© 2000 European Renal Association-European Dialysis and Transplant Association

Determinants of urinary excretion of Tamm–Horsfall protein in non-selected kidney stone formers and healthy subjects

Anna Glauser1, Werner Hochreiter2, Philippe Jaeger2 and Bernhard Hess1,

1 Section of General Internal Medicine and 2 Department of Urology, Nephrology and Rheumatology, University Hospital, Berne, Switzerland

Background. The aim of the study was to measure urinary excretion of Tamm–Horsfall protein (THP), an important inhibitor of crystallization, and to identify possible determinants of urinary THP excretion in non-selected kidney stone formers (SF) and healthy subjects (C).

Methods. By means of a commercially available ELISA (Pharmacia and Upjohn/Elias, Germany), we measured THP in 24-h urines of 104 SF (74 males/30 females, age 16–74 years) who had formed 8.7±2.4 stones (range 1–240), and of 71 C (41 males/30 females, age 22–62 years). Types of stones formed by SF were 88 calcium, eight uric acid, six infection, and two cystine. All values are means±SE.

Results. The normal range (5th to 95th percentile) of UTHPxV was 9.3–35.0 mg/day in males and 9.0–36.3 mg/day in females respectively. Mean UTHPxV was 21.3±1.2 mg/day (range 3.4–51.6) in male and 15.2±1.6 mg/day (range 1.8–32.3) in female SF (P=0.008 vs male SF). Since UTHPxV was positively correlated with CCrea (r=0.312, P=0.001) in SF as well as with UCreaxV (r=0.346, P=0.0001) and with body surface (r=0.271, P=0.0003) in all study subjects, mean THP/Crea (mg/mmol) was used for all further calculations. Overall, THP/Crea was lower in SF (1.42±0.07 vs 1.68±0.08, P=0.015), mainly due to increased THP/Crea in female C (2.08±0.11, P=0.0036 vs female SF, P=0.0001 vs male C and vs male calcium SF), which also explains decreased THP/Crea values in calcium SF (1.46±0.08, P=0.041 vs C). In addition, THP/Crea was reduced in uric acid SF (1.11±0.21, P=0.049 vs C). Whereas THP/Crea was not related to age, urine volume, intake of dairy calcium, or urinary markers of protein intake, either in C or in SF, it correlated significantly with urinary Citrate/Crea, both in C (r=0.523, P=0.0001) and in SF (r=0.221, P=0.025). In C only, but not in SF, THP/Crea was correlated with urinary Calcium/Crea (r=0.572, P=0.0001) and with Oxalate/Crea (r=0.274, P=0.022).

Conclusions. Both in C and SF, urinary THP excretion is related to body size, renal function and urinary citrate excretion, whereas dietary habits apparently do not affect THP excretion. Uric acid and calcium stone formation predict reduced THP excretion in comparison with C, whereas female gender goes along with increased urinary THP excretion in C. Possibly most relevant to kidney stone formation is the fact that THP excretion rises only in C in response to increasing urinary calcium and oxalate concentrations, whereas this self-protective mechanism appears to be missing in SF.

Keywords: hypercalciuria; hyperoxaluria; inhibitors of crystallization; modulators of crystallization; nephrolithiasis; Tamm–Horsfall protein (THP)

Correspondence and offprint requests to: PD Dr B. Hess, Chief of Internal Medicine, Hospital Zimmerberg, CH-8820 Wädenswil/Zurich, Switzerland.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. J. Bergsland, J. K. Kelly, B. J. Coe, and F. L. Coe
Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F530 - F536.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Terris, G. T. Lesser, B. Dawson-Hughes, R. D. Jackson, A. Z. LaCroix, and the Women's Health Initiative Investigators
Calcium plus vitamin D and the risk of fractures.
N. Engl. J. Med., May 25, 2006; 354(21): 2285 - 2287.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Devuyst, K. Dahan, and Y. Pirson
Tamm-Horsfall protein or uromodulin: new ideas about an old molecule
Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1290 - 1294.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. A. Wesson, R. J. Johnson, M. Mazzali, A. M. Beshensky, S. Stietz, C. Giachelli, L. Liaw, C. E. Alpers, W. G. Couser, J. G. Kleinman, et al.
Osteopontin Is a Critical Inhibitor of Calcium Oxalate Crystal Formation and Retention in Renal Tubules
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 139 - 147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Zhu, J. Cheng, J. Gao, H. Lepor, Z.-T. Zhang, J. Pak, and X.-R. Wu
Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice
Am J Physiol Renal Physiol, April 1, 2002; 282(4): F608 - F617.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.